Handelsbanken Fonder
KRTX

Handelsbanken Fonder’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Handelsbanken Fonder’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,000
Closed -$2.22M – 1576
2023
Q4 		$2.22M Buy
7,000
+1,300
+23% +$253K 0.01% 537
2023
Q3 		$964K Buy
5,700
+600
+12% +$113K 0.01% 742
2023
Q2 		$1.11M Buy
5,100
+1,300
+34% +$279K 0.01% 706
2023
Q1 		$690K Hold
3,800
– – ﹤0.01% 850
2022
Q4 		$747K Hold
3,800
– – ﹤0.01% 751
2022
Q3 		$855K Buy
3,800
+400
+12% +$81K 0.01% 711
2022
Q2 		$430K Hold
3,400
– – ﹤0.01% 1112
2022
Q1 		$431K Sell
3,400
-1,900
-36% -$214K ﹤0.01% 1310
2021
Q4 		$694K Sell
5,300
-300
-5% -$38.8K ﹤0.01% 1127
2021
Q3 		$685K Buy
5,600
+1,300
+30% +$150K ﹤0.01% 1131
2021
Q2 		$490K Buy
4,300
+600
+16% +$70.1K ﹤0.01% 1397
2021
Q1 		$445K Hold
3,700
– – ﹤0.01% 1259
2020
Q4 		$376K Buy
+3,700
New +$343K ﹤0.01% 1308
2020
Q3 		– Sell
-2,200
Closed -$245K – 1473
2020
Q2 		$245K Buy
+2,200
New +$191K ﹤0.01% 1306

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Handelsbanken Fonder's KRTX Position: Q1 2024 in Review

Handelsbanken Fonder sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 7,000 shares — an estimated $2.22M sold.

Handelsbanken Fonder first reported a position in KRTX in Q2 2020 and held it in 14 quarters. The position peaked at $2.22M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Handelsbanken Fonder reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Handelsbanken Fonder sold 7,000 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.22M.
  • Handelsbanken Fonder first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
  • Handelsbanken Fonder's Karuna Therapeutics, Inc. Common Stock position peaked at $2.22M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Handelsbanken Fonder's 13F filing for Q1 2024, filed 13 May 2024.